Mammoth Biosciences vs Moderna
Mammoth Biosciences vs Moderna, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Mammoth Biosciences is on 63/100 and Moderna on 77/100.
Where each one leads
Mammoth Biosciences
Leads on none of the measures we hold for both companies.
Moderna
- our overall score: 77/100 against 63/100
- agent readiness: 49/100 against 35/100
- domain rating: 79/100 against 53/100
- headcount: 6,297 against 165
- funding raised: $4.5B against $460M
- LinkedIn following: 780,086 against 57,986
At a glance
| Measure | Mammoth Biosciences | Moderna |
|---|---|---|
| What it is | Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics. | Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics. |
| Category | Biotechnology, Drug Discovery, Genomics, CRISPR Technology | Biotechnology, mRNA Technology, Vaccines, Pharmaceuticals |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2017 | 2010 |
| Headquarters | Brisbane, United States | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Mammoth Biosciences | Moderna |
|---|---|---|
| Employees | 165 | 6,297 |
| Headcount growthLast 12 months | +5.8% | Not published |
| Open roles | Not published | 99 |
| Total funding | $460M | $4.5B |
| Latest round | Funding Round | Funding Round |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 57,986 | 780,086 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Mammoth Biosciences | Moderna |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 63/100 | 77/100 |
| Traction | 60/100 | 60/100 |
| Team | 70/100 | 70/100 |
| Community | Not published | 13/100 |
| Search visibility | 35/100 | 46/100 |
| Quality | 68/100 | 90/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (35/100) | D (49/100) |
| Domain ratingLink authority, 0-100 | 53/100 | 79/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Mammoth Biosciences | Moderna |
|---|---|---|
| Hosting | Not detected | AWS |
| CDN | Not detected | CloudFront |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Next.js |
| Analytics | Google Analytics 4 | Not detected |
What users say
| Measure | Mammoth Biosciences | Moderna |
|---|---|---|
| Community ratingVisitor votes on StartupHub | Not published | 2.0/5 from 1 vote |
Mammoth Biosciences vs Moderna: common questions
Which is better, Mammoth Biosciences or Moderna?
On our 0-100 score Moderna rates higher (77/100 against 63/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Mammoth Biosciences and Moderna compare on the numbers?
Moderna leads on our overall score (77/100 against 63/100), agent readiness (49/100 against 35/100), domain rating (79/100 against 53/100), headcount (6,297 against 165), funding raised ($4.5B against $460M), LinkedIn following (780,086 against 57,986).
Read the full Mammoth Biosciences review and pricing or the Moderna review and pricing. You can also browse other Mammoth Biosciences alternatives we track.